Silicon Valley-based genetic testing company 23andMe Inc has raised $115 million in venture capital financing, as it prepares to introduce a new consumer product and expand its drug discovery arm
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
